Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 71335-2407

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 71335-2407). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorvastatinfigure1. (Atorvastatinfigure1)

Chemical structure of atorvastatin calcium, showing the molecular arrangement including phenyl groups, hydroxyl groups, and a calcium ion complexed with three water molecules.*

FDA Label Image

Atorvastatinfigure2. (Atorvastatinfigure2)

A line graph comparing the cumulative incidence percentages of events over a 3.5-year period for Atorvastatin versus a placebo. The x-axis represents time in years, and the y-axis shows cumulative incidence percentage. The graph includes a hazard ratio and p-value indicating statistical comparison between the two groups.*

FDA Label Image

Atorvastatinfigure3. (Atorvastatinfigure3)

A line chart showing cumulative hazard percentages over a time span of 0 to 5 years. It compares two groups labeled 'Placebo' and 'Atorvastatin,' with the placebo group having higher cumulative hazard over time. The chart includes a hazard ratio (HR) of 0.63 with a confidence interval (0.48-0.83) and a p-value of 0.001, indicating statistical analysis of time to first primary endpoint during up to four years of follow-up.*

FDA Label Image

Atorvastatinfigure4. (Atorvastatinfigure4)

A Kaplan-Meier survival curve comparing time to first major cardiovascular endpoint over five years for atorvastatin 10 mg and atorvastatin 80 mg dosing. The graph plots the proportion of subjects experiencing the event over time, showing lower event rates with atorvastatin 80 mg. It includes a hazard ratio (HR 0.78) with confidence intervals and a p-value.*

FDA Label Image

Atorvastatinfigure9 (Atorvastatinfigure9)

FDA Label Image

Label (Lbl713352407)

The label for Atorvastatin Calcium Tablets, USP, 80 mg film-coated oral tablets, repackaged by Bryant Ranch Prepack, Inc. and manufactured by Annora Pharma Pvt. Ltd. It includes the NDC 71335-2407, indicates a quantity of 30 tablets, and provides storage instructions (20° to 25°C). The label also advises to keep the container tightly closed and out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.